News | Ultrasound Imaging | June 01, 2021

Placental bulge sign on prenatal ultrasound or MRI helps diagnose severe placental accreta spectrum disorder warranting hysterectomy rather than conservative management

A) Ultrasound in 28-year-old woman (B) MRI in 34-year-old woman with suspected PAS disorder. Focal area of placental tissues bulge toward imaginary lines of normal uterine contour (dash lines). Length (L) and depth (D) measurements of placental bulge also demonstrated. p = placenta; b = bladder. Image courtesy of American Roentgen Ray Society (ARRS), American Journal of Roentgenology (AJR)

A) Ultrasound in 28-year-old woman (B) MRI in 34-year-old woman with suspected PAS disorder. Focal area of placental tissues bulge toward imaginary lines of normal uterine contour (dash lines). Length (L) and depth (D) measurements of placental bulge also demonstrated. p = placenta; b = bladder. Image courtesy of American Roentgen Ray Society (ARRS), American Journal of Roentgenology (AJR)


June 1, 2021 — According to an open-access Editor's Choice article in ARRS' American Journal of Roentgenology (AJR), accurate prenatal diagnosis of severe placental accreta spectrum (PAS) disorder by imaging could help guide maternal counseling and selection between hysterectomy and uterine-preserving surgery.

"The findings suggest strong performance of placental bulge in diagnosing severe PAS on both ultrasound and MRI, with potentially relatively stronger performance on MRI," wrote corresponding author Manjiri Dighe from the department of radiology at the University of Washington School of Medicine. "Nonetheless, interobserver agreement remains suboptimal on both modalities."

On ultrasound and MRI alike, the placental bulge sign represents deeper venous invasion in PAS—the focal area of myometrial-placental bulging beyond the normal uterine contour. Dighe and colleagues' retrospective study included 62 pregnant women (mean age, 33.2 years) with clinically suspected PAS who underwent both ultrasound and MRI. Blinded to final diagnoses, two maternal-fetal medicine specialists for ultrasound and three abdominal radiologists for MRI independently reviewed images for their respective modality. Using intraoperative and pathologic findings, alongside International Federation of Gynaecology and Obstetrics classification, patients were separated into those with and without severe PAS.

"In diagnosing severe PAS," Dighe et al. noted, "placental bulge sign achieved on ultrasound an accuracy of 85.5%, sensitivity of 91.7%, and specificity of 76.9%, and on MRI an accuracy of 90.3%, sensitivity of 94.4%, and specificity of 84.6%." Ultimately, placental bulge was an independent predictor of severe PAS on ultrasound (odds ratio=8.94) and MRI (odds ratio=45.67).

"Placental bulge sign on either prenatal ultrasound or MRI may help diagnose severe PAS warranting hysterectomy rather than conservative management," the authors of this AJR article concluded.

For more information: www.arrs.org


Related Content

News | PET Imaging

April 24, 2024 — A new study from Brigham and Women’s Hospital, a founding member of the Mass General Brigham healthcare ...

Time April 24, 2024
arrow
News | Contrast Media

April 24, 2024 — The International Contrast Ultrasound Society (ICUS) and Northwest Imaging Forums (NWIF) announced an ...

Time April 24, 2024
arrow
News | Radiology Business

April 23, 2024 — A diverse writing group—lead by authors at the University of Toronto—have developed an approach for ...

Time April 23, 2024
arrow
News | FDA

April 23, 2024 — Royal Philips , a global leader in health technology, today announced its Philips Zenition 30 mobile C ...

Time April 23, 2024
arrow
News | Ultrasound Imaging

April 22, 2024 — GE HealthCare announced the launch of the Voluson Signature 20 and 18 ultrasound systems, which ...

Time April 22, 2024
arrow
News | Lung Imaging

April 17, 2024 — A Medicare policy requiring primary care providers (PCPs) to share in the decision-making with patients ...

Time April 17, 2024
arrow
News | Radiology Business

April 17, 2024 — VISTA.AI announced the appointment of Daniel Hawkins as President and CEO. The company is pioneering AI ...

Time April 17, 2024
arrow
News | Magnetic Resonance Imaging (MRI)

April 17, 2024 — Hyperfine, Inc., a groundbreaking health technology company that has redefined brain imaging with the ...

Time April 17, 2024
arrow
News | Mammography

April 16, 2024 — The Radiological Society of North America (RSNA) and GE HealthCare announced their collaboration to ...

Time April 16, 2024
arrow
News | Clinical Trials

April 16, 2024 — QT Imaging Holdings, Inc., a medical device company engaged in research, development, and ...

Time April 16, 2024
arrow
Subscribe Now